Skip to content
MARKETS / NASDAQ / PRVA
NASDAQ · SERVICES-HEALTH SERVICES · LARGE CAP

Privia Health Group, Inc. PRVA

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.1B
▲ 22.3% YoY
$22.9M
▲ 59.3% YoY
In brief

What this company does

It holds the provider contracts, maintains the patient records, sets reimbursement rates, and negotiates payer contracts on behalf of the Owned Medical Groups. It currently has a presence in 24 states and the District of Columbia, including 9 states in which it only participates in VBC arrangements. As of December 31, 2025, it had 5,380 Privia Providers who are credentialed and bill for medical services, across Owned and Non-Owned Medical Groups. Its implemented providers operate in over 1,300 practice locations. Privia cares for over 5.8 million patients. As of December 31, 2025, across Privia Health Group, Inc., it had 1,226 employees in 43 states and the District of Columbia. It owns a majority interest in certain of its Medical Groups, termed Owned Medical Groups, with Privia Physicians collectively owning a minority interest, and owns no interest in certain other Medical Groups, termed Non-Owned Medical Groups, for which it provides services through a services agreement. Privia Health Group, Inc. was incorporated in Delaware in 2016.

Written from the business description in Privia Health Group, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth
USD 2.1B
Revenue, FY2025 · full 7-year series below
Revenue $B Net income $B
FY2025 · Revenue 2.1 · Net income 0.0
0.8B1.6B2019202020212022202320242025
Compound annual growth
+16.1%
+21.0%
−6.0%
−11.4%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +21.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
1 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 1.6% · Net 1.4%
1%2%3%-10%-20%2019202020212022202320242025
ROE
FY2025 · ROE 3.3%
10%20%-20%-40%-60%2019202020212022202320242025

Each USD of equity produced 3 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2023 · FCF 80.7
40M80M2019202020212022202320242025

Total assetsUSD 1.4B
EquityUSD 737.2M
CashUSD 479.7M
Current ratio1.60×

Equity funds 54% of total assets.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B2.11.71.71.41.00.80.8
Operating income $B0.00.00.0−0.0−0.20.00.0
EBITDA $B0.00.00.0−0.0−0.20.00.0
Income tax $B0.00.00.0−0.0−0.0−0.00.0
Net income $B0.00.00.0−0.0−0.20.00.0
Free cash flow $B··0.10.00.10.00.0
EPS, diluted $0.180.110.19−0.08−1.830.330.09
Dividend / sh $·······
Payout %·······
ROE %3.32.44.4−1.9−65.621.3·
Shares out B0.120.120.120.110.110.10·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 26 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 50 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image